Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective studyYujuan Liu, Xian Zhu, Rongxin Li, Jun Zhang, Feng Zhang
26 November 2020
Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims databaseAmelia Smith, Michael Barry
14 November 2020
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesSophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, Jules Desmeules, Marie Besson, Markus Kosel
4 November 2020
Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodologyAmna Saeed, Hamid Saeed, Zikria Saleem, Caijun Yang, Minghuan Jiang, Mingyue Zhao, Wenjing Ji, Muhammad Majid Aziz, Faiz Ullah Khan, Ali Hassan Gillani, Naveel Atif, Yu Fang, Zaheer Ud Din Babar
8 October 2020
Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studiesBernadette Clara Francisca Maria Schutijser, Irene Jongerden, Joanna Ewa Klopotowska, Marco Moesker, Maaike Langelaan, Cordula Wagner, Martine de Bruijne
30 September 2020
Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocolHarsukh Benipal, Anne Holbrook, J. Michael Paterson, James Douketis, Gary Foster, Lehana Thabane
22 September 2020
Medication-related experiences of patients with polypharmacy: a systematic review of qualitative studiesChristian Ulrich Eriksen, Stavros Kyriakidis, Line Due Christensen, Ramune Jacobsen, Jannie Laursen, Mikkel Bring Christensen, Anne Frølich
6 September 2020
Adverse effects information in clinical guidelines on pharmacological treatment of depression in children and adolescents: a systematic reviewTone Westergren, Sigrid Narum, Marianne Klemp
20 July 2020
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional studyThomas J Moore, James Heyward, Gerard Anderson, G Caleb Alexander
11 June 2020
Chinese physicians’ attitudes toward eco-directed sustainable prescribing from the perspective of ecopharmacovigilance: a cross-sectional studyJun Wang, Shulan Li, Bingshu He
1 June 2020
